ExploreWatchlistsPricing
  1. JP-listed companies
  2. TERUMO CORPORATION
  3. Financials
  4. Marketable securities, current

TERUMO CORPORATION (4543)

Market cap
¥3.35T
P/E ratio
20.2x
Terumo develops medical devices and solutions for heart treatment, clinical care, and blood technology to support healthcare delivery worldwide.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndMarketable securities, current (Million JPY)YoY (%)
Mar 31, 2026236-39.18%
Mar 31, 2025388-98.52%
Mar 31, 202426,158+24577.36%
Mar 31, 2023106+68.25%
Mar 31, 202263-94.35%
Mar 31, 20211,116+181.11%
Mar 31, 2020397-77.24%
Mar 31, 20191,744+164.64%
Mar 31, 2018659-98.68%
Mar 31, 201550,000

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat